Difference between revisions of "SMARCA4-deficient sinonasal carcinoma"

From Libre Pathology
Jump to navigation Jump to search
 
Line 10: Line 10:
DDx:<ref name=pmid34871352>{{cite journal |authors=Kakkar A, Ashraf SF, Rathor A, Adhya AK, Mani S, Sikka K, Jain D |title=SMARCA4/BRG1-Deficient Sinonasal Carcinoma |journal=Arch Pathol Lab Med |volume=146 |issue=9 |pages=1122–1130 |date=September 2022 |pmid=34871352 |doi=10.5858/arpa.2021-0001-OA |url=}}</ref>
DDx:<ref name=pmid34871352>{{cite journal |authors=Kakkar A, Ashraf SF, Rathor A, Adhya AK, Mani S, Sikka K, Jain D |title=SMARCA4/BRG1-Deficient Sinonasal Carcinoma |journal=Arch Pathol Lab Med |volume=146 |issue=9 |pages=1122–1130 |date=September 2022 |pmid=34871352 |doi=10.5858/arpa.2021-0001-OA |url=}}</ref>
*[[Sinonasal undifferentiated carcinoma]] (SNUC).
*[[Sinonasal undifferentiated carcinoma]] (SNUC).
*Neuroendocrine carcinoma - [[small cell carcinoma]] and [[large cell neuroendocrine carcinoma]].
*Neuroendocrine carcinoma - [[small cell carcinoma]] or [[large cell neuroendocrine carcinoma]].
*Teratocarcinosarcoma.
*Teratocarcinosarcoma.



Latest revision as of 17:49, 20 December 2023

SMARCA4-deficient sinonasal carcinoma is an emerging type of sinonasal carcinoma.[1]

General

Microscopic

Features:

  • Poorly differentiated tumour with large or small cells.

DDx:[2]

IHC

Features:[1]

  • SMARCA4 loss of staining - definitional.
  • CK5 -ve.
  • p63 -ve.
  • p16 -ve.
  • NUT -ve.

See also

References

  1. 1.0 1.1 "SMARCA4-deficient Sinonasal Carcinoma: A Series of 10 Cases Expanding the Genetic Spectrum of SWI/SNF-driven Sinonasal Malignancies". Am J Surg Pathol 44 (5): 703–710. May 2020. doi:10.1097/PAS.0000000000001428. PMID 31934917.
  2. 2.0 2.1 Kakkar A, Ashraf SF, Rathor A, Adhya AK, Mani S, Sikka K, Jain D (September 2022). "SMARCA4/BRG1-Deficient Sinonasal Carcinoma". Arch Pathol Lab Med 146 (9): 1122–1130. doi:10.5858/arpa.2021-0001-OA. PMID 34871352.